Suppr超能文献

肝细胞焦亡和炎性小体颗粒的释放诱导肝星状细胞活化和肝纤维化。

Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis.

机构信息

Department of Pediatrics, University of California San Diego, La Jolla, CA, USA; Universität Leipzig, Klinik und Poliklinik für Kardiologie, Leipzig, Germany.

Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.

出版信息

J Hepatol. 2021 Jan;74(1):156-167. doi: 10.1016/j.jhep.2020.07.041. Epub 2020 Aug 4.

Abstract

BACKGROUND & AIMS: Increased hepatocyte death contributes to the pathology of acute and chronic liver diseases. However, the role of hepatocyte pyroptosis and extracellular inflammasome release in liver disease is unknown.

METHODS

We used primary mouse and human hepatocytes, hepatocyte-specific leucine 351 to proline Nlrp3CreA mice, and Gsdmd mice to investigate pyroptotic cell death in hepatocytes and its impact on liver inflammation and damage. Extracellular NOD-, LRR-, and pyrin domain-containing protein 3 (NLRP3) inflammasomes were isolated from mutant NLRP3-YFP HEK cells and internalisation was studied in LX2 and primary human hepatic stellate cells. We also examined a cohort of 154 adult patients with biopsy-proven non-alcoholic fatty liver disease (Sir Charles Gairdner Hospital, Nedlands, Western Australia).

RESULTS

We demonstrated that primary mouse and human hepatocytes can undergo pyroptosis upon NLRP3 inflammasome activation with subsequent release of NLRP3 inflammasome proteins that amplify and perpetuate inflammasome-driven fibrogenesis. Pyroptosis was inhibited by blocking caspase-1 and gasdermin D activation. The activated form of caspase-1 was detected in the livers and in serum from patients with non-alcoholic steatohepatitis and correlated with disease severity. Nlrp3CreA mice showed spontaneous liver fibrosis under normal chow diet, and increased sensitivity to liver damage and inflammation after treatment with low dose lipopolysaccharide. Mechanistically, hepatic stellate cells engulfed extracellular NLRP3 inflammasome particles leading to increased IL-1β secretion and α-smooth muscle actin expression. This effect was abrogated when cells were pre-treated with the endocytosis inhibitor cytochalasin B.

CONCLUSIONS

These results identify hepatocyte pyroptosis and release of inflammasome components as a novel mechanism to propagate liver injury and liver fibrosis development.

LAY SUMMARY

Our findings identify a novel mechanism of inflammation in the liver. Experiments in cell cultures, mice, and human samples show that a specific form of cell death, called pyroptosis, leads to the release of complex inflammatory particles, the NLRP3 inflammasome, from inside hepatocytes into the extracellular space. From there they are taken up by other cells and thereby mediate inflammatory and pro-fibrogenic stress signals. The discovery of this mechanism may lead to novel treatments for chronic liver diseases in the future.

摘要

背景与目的

肝细胞死亡增加导致急性和慢性肝病的病理变化。然而,肝细胞细胞焦亡和细胞外炎性小体释放在肝病中的作用尚不清楚。

方法

我们使用原代小鼠和人肝细胞、肝特异性亮氨酸 351 至脯氨酸 Nlrp3CreA 小鼠和 Gsdmd 小鼠,研究了肝细胞细胞焦亡及其对肝炎症和损伤的影响。从突变型 NLRP3-YFP HEK 细胞中分离出细胞外 NOD、LRR 和吡喃结构域蛋白 3(NLRP3)炎性小体,并在 LX2 和原代人肝星状细胞中研究其内化情况。我们还检查了来自 154 名经活检证实的非酒精性脂肪性肝病患者的队列(西澳大利亚州尼德兰兹的查尔斯·盖尔德纳医院)。

结果

我们证明,原代小鼠和人肝细胞在 NLRP3 炎性小体激活后可发生细胞焦亡,随后释放 NLRP3 炎性小体蛋白,放大和维持炎性小体驱动的纤维发生。细胞焦亡可通过阻断半胱天冬酶-1 和 Gasdermin D 的激活来抑制。在非酒精性脂肪性肝炎患者的肝脏和血清中检测到活化形式的半胱天冬酶-1,其与疾病严重程度相关。在正常饲料下,Nlrp3CreA 小鼠自发发生肝纤维化,并且在用低剂量脂多糖治疗后对肝损伤和炎症的敏感性增加。在机制上,肝星状细胞吞噬细胞外 NLRP3 炎性小体颗粒,导致 IL-1β 分泌和 α-平滑肌肌动蛋白表达增加。当细胞用胞吞抑制剂细胞松弛素 B 预处理时,这种作用被阻断。

结论

这些结果确定了肝细胞焦亡和炎性小体成分的释放是促进肝损伤和肝纤维化发展的新机制。

要点总结

我们的发现确定了肝脏炎症的一种新机制。细胞培养、小鼠和人类样本中的实验表明,一种称为细胞焦亡的特定细胞死亡形式导致 NLRP3 炎性小体等复杂炎症颗粒从肝细胞内释放到细胞外空间。从那里,它们被其他细胞摄取,并由此介导炎症和促纤维化应激信号。这种机制的发现可能为未来的慢性肝病治疗带来新的方法。

相似文献

1
Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis.
J Hepatol. 2021 Jan;74(1):156-167. doi: 10.1016/j.jhep.2020.07.041. Epub 2020 Aug 4.
2
Antcin A alleviates pyroptosis and inflammatory response in Kupffercells of non-alcoholic fatty liver disease by targeting NLRP3.
Int Immunopharmacol. 2021 Nov;100:108126. doi: 10.1016/j.intimp.2021.108126. Epub 2021 Sep 4.
4
Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy.
Eur J Pharmacol. 2019 Dec 1;864:172715. doi: 10.1016/j.ejphar.2019.172715. Epub 2019 Oct 5.
5
NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice.
Hepatology. 2014 Mar;59(3):898-910. doi: 10.1002/hep.26592. Epub 2014 Jan 30.
6
Cell-specific Deletion of NLRP3 Inflammasome Identifies Myeloid Cells as Key Drivers of Liver Inflammation and Fibrosis in Murine Steatohepatitis.
Cell Mol Gastroenterol Hepatol. 2022;14(4):751-767. doi: 10.1016/j.jcmgh.2022.06.007. Epub 2022 Jul 2.
7
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.
J Hepatol. 2017 May;66(5):1037-1046. doi: 10.1016/j.jhep.2017.01.022. Epub 2017 Feb 3.
8
STING mediates hepatocyte pyroptosis in liver fibrosis by Epigenetically activating the NLRP3 inflammasome.
Redox Biol. 2023 Jun;62:102691. doi: 10.1016/j.redox.2023.102691. Epub 2023 Mar 29.
9
Gentiopicroside improves NASH and liver fibrosis by suppressing TLR4 and NLRP3 signaling pathways.
Biomed Pharmacother. 2024 Aug;177:116952. doi: 10.1016/j.biopha.2024.116952. Epub 2024 Jun 24.

引用本文的文献

3
Butein Alleviates Non-Alcoholic Steatohepatitis in Leptin-Deficient Mice by Modulating the PDE4/cAMP/p-CREB Pathway.
Drug Des Devel Ther. 2025 Aug 14;19:7015-7031. doi: 10.2147/DDDT.S530855. eCollection 2025.
4
SENP3 protects hepatocyte from pyroptosis during acute liver injury through deSUMOylation of HNRNPL.
iScience. 2025 Jul 7;28(8):113067. doi: 10.1016/j.isci.2025.113067. eCollection 2025 Aug 15.
5
SRPK1 is a significant factor in driving the progression of diabetic kidney fibrosis.
Diabetol Metab Syndr. 2025 Aug 6;17(1):316. doi: 10.1186/s13098-025-01889-0.
7
Role of NLRP3 in the metabolism of bile acids and gut microbiota in CCl4-induced liver fibrosis.
Microbiol Spectr. 2025 Jul 21:e0014825. doi: 10.1128/spectrum.00148-25.
8
Ferroptosis as a potential therapeutic target for obesity-related metabolic diseases.
Front Pharmacol. 2025 Jul 4;16:1581632. doi: 10.3389/fphar.2025.1581632. eCollection 2025.
10
Therapeutic approaches for liver fibrosis/cirrhosis by targeting pyroptosis.
Open Life Sci. 2025 Jul 11;20(1):20251092. doi: 10.1515/biol-2025-1092. eCollection 2025.

本文引用的文献

1
ASK1 inhibition reduces cell death and hepatic fibrosis in an Nlrp3 mutant liver injury model.
JCI Insight. 2020 Jan 30;5(2):123294. doi: 10.1172/jci.insight.123294.
2
Effect of glucose and insulin supplementation on the isolation of primary human hepatocytes.
EXCLI J. 2019 Nov 18;18:1071-1091. doi: 10.17179/excli2019-1782. eCollection 2019.
3
The gasdermins, a protein family executing cell death and inflammation.
Nat Rev Immunol. 2020 Mar;20(3):143-157. doi: 10.1038/s41577-019-0228-2. Epub 2019 Nov 5.
5
Novel Drivers of the Inflammatory Response in Liver Injury and Fibrosis.
Semin Liver Dis. 2019 Jul;39(3):275-282. doi: 10.1055/s-0039-1685515. Epub 2019 May 17.
7
Gasdermin D mediates the pathogenesis of neonatal-onset multisystem inflammatory disease in mice.
PLoS Biol. 2018 Nov 2;16(11):e3000047. doi: 10.1371/journal.pbio.3000047. eCollection 2018 Nov.
9
Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.
J Hepatol. 2018 Apr;68(4):773-782. doi: 10.1016/j.jhep.2017.11.040. Epub 2017 Dec 20.
10
Human hepatic stellate cell isolation and characterization.
J Gastroenterol. 2018 Jan;53(1):6-17. doi: 10.1007/s00535-017-1404-4. Epub 2017 Nov 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验